nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.206	0.318	CbGbCtD
Dutasteride—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0944	0.146	CbGbCtD
Dutasteride—SRD5A1—Androgen biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.0868	0.298	CbGpPWpGaD
Dutasteride—SRD5A2—Androgen biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.0868	0.298	CbGpPWpGaD
Dutasteride—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0865	0.134	CbGbCtD
Dutasteride—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0862	0.133	CbGbCtD
Dutasteride—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0802	0.124	CbGbCtD
Dutasteride—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0368	0.0569	CbGbCtD
Dutasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.036	0.124	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.036	0.124	CbGpPWpGaD
Dutasteride—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0337	0.0522	CbGbCtD
Dutasteride—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.023	0.0356	CbGbCtD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00369	0.0127	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00369	0.0127	CbGpPWpGaD
Dutasteride—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00361	0.0124	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00243	0.00837	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00243	0.00837	CbGpPWpGaD
Dutasteride—Hyperaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.0365	CcSEcCtD
Dutasteride—Hyperaesthesia—Tretinoin—peripheral nervous system neoplasm	0.00228	0.0365	CcSEcCtD
Dutasteride—Neoplasm malignant—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.0336	CcSEcCtD
Dutasteride—Neoplasm malignant—Tretinoin—peripheral nervous system neoplasm	0.0021	0.0336	CcSEcCtD
Dutasteride—Neoplasm malignant—Melphalan—peripheral nervous system neoplasm	0.00207	0.0331	CcSEcCtD
Dutasteride—Tenderness—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.0329	CcSEcCtD
Dutasteride—Tenderness—Tretinoin—peripheral nervous system neoplasm	0.00205	0.0329	CcSEcCtD
Dutasteride—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00198	0.0068	CbGpPWpGaD
Dutasteride—Hyperaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.0277	CcSEcCtD
Dutasteride—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00168	0.00577	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00164	0.00565	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00164	0.00565	CbGpPWpGaD
Dutasteride—Neoplasm—Topotecan—peripheral nervous system neoplasm	0.00163	0.0261	CcSEcCtD
Dutasteride—Neoplasm—Melphalan—peripheral nervous system neoplasm	0.0016	0.0256	CcSEcCtD
Dutasteride—Neoplasm malignant—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.0254	CcSEcCtD
Dutasteride—Tenderness—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.0249	CcSEcCtD
Dutasteride—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.0014	0.00482	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00137	0.0047	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00137	0.0047	CbGpPWpGaD
Dutasteride—Cardiac failure—Tretinoin—peripheral nervous system neoplasm	0.00133	0.0213	CcSEcCtD
Dutasteride—Cardiac failure—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.0213	CcSEcCtD
Dutasteride—Tenderness—Cisplatin—peripheral nervous system neoplasm	0.00132	0.0212	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—GNS—peripheral nervous system neoplasm	0.00119	0.00409	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GNS—peripheral nervous system neoplasm	0.00119	0.00409	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NME1—peripheral nervous system neoplasm	0.00114	0.00392	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NME1—peripheral nervous system neoplasm	0.00114	0.00392	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—COX2—peripheral nervous system neoplasm	0.0011	0.00377	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—COX2—peripheral nervous system neoplasm	0.0011	0.00377	CbGpPWpGaD
Dutasteride—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00108	0.00372	CbGpPWpGaD
Dutasteride—Cardiac failure—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.0162	CcSEcCtD
Dutasteride—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.000818	0.0131	CcSEcCtD
Dutasteride—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.000801	0.0128	CcSEcCtD
Dutasteride—Cardiac failure—Etoposide—peripheral nervous system neoplasm	0.000787	0.0126	CcSEcCtD
Dutasteride—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.000787	0.0126	CcSEcCtD
Dutasteride—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.000787	0.0126	CcSEcCtD
Dutasteride—Breast disorder—Cisplatin—peripheral nervous system neoplasm	0.000758	0.0121	CcSEcCtD
Dutasteride—Hyperaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000756	0.0121	CcSEcCtD
Dutasteride—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.000755	0.0121	CcSEcCtD
Dutasteride—Angioedema—Topotecan—peripheral nervous system neoplasm	0.000721	0.0115	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—ENO2—peripheral nervous system neoplasm	0.00072	0.00248	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00072	0.00248	CbGpPWpGaD
Dutasteride—Hyperaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000699	0.0112	CcSEcCtD
Dutasteride—Neoplasm malignant—Epirubicin—peripheral nervous system neoplasm	0.000695	0.0111	CcSEcCtD
Dutasteride—Breast pain—Epirubicin—peripheral nervous system neoplasm	0.00068	0.0109	CcSEcCtD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000652	0.00224	CbGpPWpGaD
Dutasteride—Neoplasm malignant—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.0103	CcSEcCtD
Dutasteride—Breast pain—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.0101	CcSEcCtD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000621	0.00214	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000609	0.00209	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000609	0.00209	CbGpPWpGaD
Dutasteride—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000597	0.00956	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000581	0.002	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000581	0.002	CbGpPWpGaD
Dutasteride—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000575	0.00921	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—TH—peripheral nervous system neoplasm	0.000572	0.00197	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—TH—peripheral nervous system neoplasm	0.000572	0.00197	CbGpPWpGaD
Dutasteride—Neoplasm—Epirubicin—peripheral nervous system neoplasm	0.000536	0.0086	CcSEcCtD
Dutasteride—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000524	0.0084	CcSEcCtD
Dutasteride—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000511	0.00819	CcSEcCtD
Dutasteride—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000507	0.00813	CcSEcCtD
Dutasteride—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000507	0.00813	CcSEcCtD
Dutasteride—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000501	0.00802	CcSEcCtD
Dutasteride—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.00795	CcSEcCtD
Dutasteride—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00048	0.00769	CcSEcCtD
Dutasteride—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000474	0.0076	CcSEcCtD
Dutasteride—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00047	0.00754	CcSEcCtD
Dutasteride—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00047	0.00754	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000467	0.00161	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000467	0.00161	CbGpPWpGaD
Dutasteride—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000464	0.00744	CcSEcCtD
Dutasteride—SRD5A1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000458	0.00158	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000458	0.00158	CbGpPWpGaD
Dutasteride—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000455	0.0073	CcSEcCtD
Dutasteride—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000452	0.00724	CcSEcCtD
Dutasteride—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000452	0.00724	CcSEcCtD
Dutasteride—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000446	0.00714	CcSEcCtD
Dutasteride—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00707	CcSEcCtD
Dutasteride—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000426	0.00682	CcSEcCtD
Dutasteride—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000422	0.00676	CcSEcCtD
Dutasteride—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000422	0.00676	CcSEcCtD
Dutasteride—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00654	CcSEcCtD
Dutasteride—Rash—Topotecan—peripheral nervous system neoplasm	0.000406	0.0065	CcSEcCtD
Dutasteride—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000405	0.0065	CcSEcCtD
Dutasteride—Rash—Tretinoin—peripheral nervous system neoplasm	0.000403	0.00645	CcSEcCtD
Dutasteride—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000403	0.00645	CcSEcCtD
Dutasteride—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000402	0.00644	CcSEcCtD
Dutasteride—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000402	0.00644	CcSEcCtD
Dutasteride—Rash—Melphalan—peripheral nervous system neoplasm	0.000397	0.00637	CcSEcCtD
Dutasteride—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000397	0.00636	CcSEcCtD
Dutasteride—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000389	0.00624	CcSEcCtD
Dutasteride—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000384	0.00616	CcSEcCtD
Dutasteride—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.00616	CcSEcCtD
Dutasteride—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.00577	CcSEcCtD
Dutasteride—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000356	0.00571	CcSEcCtD
Dutasteride—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000343	0.0055	CcSEcCtD
Dutasteride—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00548	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000332	0.00114	CbGpPWpGaD
Dutasteride—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000329	0.00527	CcSEcCtD
Dutasteride—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00032	0.00513	CcSEcCtD
Dutasteride—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000308	0.00494	CcSEcCtD
Dutasteride—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00489	CcSEcCtD
Dutasteride—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00488	CcSEcCtD
Dutasteride—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00487	CcSEcCtD
Dutasteride—Urticaria—Etoposide—peripheral nervous system neoplasm	0.0003	0.00481	CcSEcCtD
Dutasteride—Rash—Vincristine—peripheral nervous system neoplasm	0.000294	0.00471	CcSEcCtD
Dutasteride—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000294	0.00471	CcSEcCtD
Dutasteride—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000278	0.00446	CcSEcCtD
Dutasteride—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00431	CcSEcCtD
Dutasteride—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000267	0.00428	CcSEcCtD
Dutasteride—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00418	CcSEcCtD
Dutasteride—Rash—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00416	CcSEcCtD
Dutasteride—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00416	CcSEcCtD
Dutasteride—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00025	0.004	CcSEcCtD
Dutasteride—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00399	CcSEcCtD
Dutasteride—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00387	CcSEcCtD
Dutasteride—Rash—Etoposide—peripheral nervous system neoplasm	0.000238	0.00382	CcSEcCtD
Dutasteride—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000238	0.00381	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000224	0.00077	CbGpPWpGaD
Dutasteride—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00269	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	0.000162	0.000557	CbGpPWpGaD
Dutasteride—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000156	0.0025	CcSEcCtD
Dutasteride—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00249	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	0.000155	0.000534	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000154	0.00053	CbGpPWpGaD
Dutasteride—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00015	0.0024	CcSEcCtD
Dutasteride—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	0.00015	0.000514	CbGpPWpGaD
Dutasteride—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00231	CcSEcCtD
Dutasteride—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00224	CcSEcCtD
Dutasteride—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00222	CcSEcCtD
Dutasteride—Rash—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00214	CcSEcCtD
Dutasteride—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00214	CcSEcCtD
Dutasteride—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00208	CcSEcCtD
Dutasteride—SRD5A2—Metabolism—AKT1—peripheral nervous system neoplasm	0.000126	0.000433	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKT1—peripheral nervous system neoplasm	0.000126	0.000433	CbGpPWpGaD
Dutasteride—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00198	CcSEcCtD
Dutasteride—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00198	CcSEcCtD
Dutasteride—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000104	0.000358	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	9.82e-05	0.000337	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	8.3e-05	0.000285	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.92e-05	0.000272	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.8e-05	0.000268	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.54e-05	0.000259	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.22e-05	0.000248	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.95e-05	0.000239	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	6.37e-05	0.000219	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	6.25e-05	0.000215	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.57e-05	0.000157	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.86e-05	0.000133	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.68e-05	0.000126	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.63e-05	0.000125	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.96e-05	0.000102	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.91e-05	9.98e-05	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.72e-05	5.91e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.99e-06	2.75e-05	CbGpPWpGaD
